COMPARATIVE EVALUATION OF MYOCARDIAL REMODELING IN PATIENTS WITH HYPERTENSIVE DISEASE AND COMORBIDITY WITH CORONARY HEART DISEASE

Authors:

Abstract:

231 patients by hypertensive disease with II stages were inspected, 105 men and 126 women, the average ages of 52.3±1.2 years. Duration of arterial hypertension was the average 9.7±0.45 years. At 121 from 231 inspected patient’s ischemic heart disease – stable angina of II-III of functional class was diagnosed. Chronic heart failure of II-III FC (NYHA) was present at 90 from the inspected patients: at 39 (35.5 %) from 110 patients in a group with hypertensive disease and at 51 (42.1 %) from 121 – in the group of hypertensive disease in combination with coronary heart disease. Research purpose: estimation of deposit of coronary heart disease in the processes of remodeling and functional states of myocardium for the patients of hypertensive disease II the stages. It was set that tacking of coronary heart disease to hypertensive disease increases the degree of pathological remodeling of myocardium, mainly, due to dilatation of heart, and instrumental in progress of systole and diastolic dysfunction. Combination of hypertensive disease and coronary heart disease is instrumental in the increase of number of patients with violations of cardiac rhythm, including with ventricular extrasystoles of high gradation of Lown. Arterial hypertension and coronary heart disease make worse each another, and their combination results in the increase of cardiovascular risk.

Keywords:

hypertensive disease coronary heart disease structurally-functional indexes of myocardium remodeling of myocardium systolic dysfunction diastolic dysfunction

References:

1. Zharinov OI, Ivaniv YuA, Kuts VO. Funksionalna diahnostyka. 2021; 784. [in Ukrainian].
2. Unifikovanui klinichnui protokol pervynnoi, vtorynnoi (spetsializovanoi) tretynnoi (vysokospetsializovanoi) medychnoi dopomohy «Stabilna ishemichna khvoroba sertsia». 2021; 58. [in Ukrainian].
3. Al Ghorani H, Götzinger F, Böhm M, Mahfoud F. Arterial hypertension – Clinical trials update 2021. Nutr Metab Cardiovasc Dis. 2022 Jan;32(1):21-31. DOI: 10.1016/j.numecd.2021.09.007.
4. Brandt MM, Cheng C, Merkus D, Duncker DJ, Sorop O. Mechanobiology of Microvascular Function and Structure in Health and Disease: Focus on the Coronary Circulation. Front Physiol. 2021 Dec 23;12:771960. doi: 10.3389/fphys.2021.771960.
5. Cunha CLPD. Diagnóstico Eletrocardiográfico da Hipertrofia Ventricular Esquerda [Electrocardiographic Diagnosis of Left Ventricular Hypertrophy]. Arq Bras Cardiol. 2021 Nov;117(5):932-933. DOI: 10.36660/abc.20210868. [in Portuguese].
6. Cuspidi C, Gherbesi E, Tadic M. Left ventricular hypertrophy in hypertension: Is the electrocardiogram enough for risk stratification? J Clin Hypertens (Greenwich). 2023 Jan;25(1):115-116.
7. ESC 2024 Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024. DOI: 10.1093/eurheartj/ehae178.
8. Falcão-Pires I, Ferreira AF, Trindade F, Bertrand L, Ciccarelli M, Visco V et al. Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function. Eur J Heart Fail. 2024 Jul;26(7):1454-1479. doi: 10.1002/ejhf.3264.
9. Kuzminova NV, Ivankova AV, Ivanov VP, Lozinsky SE, Knyazkova II, Gavriluk AO. Structural and functional changes of the heart in patients with essential hypertension and concomitant frequent extrasystoles. World of Medicine and Biology. 2020; 2 (72): 79-85. DOI: 10.26724/2079-8334-2020-2-72-79-85.
10. Shams P, Tackling G, Borhade MB. Hypertensive Heart Disease. 2025 Apr 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.PMID:30969622.
11. Varvarousis D, Kallistratos M, Poulimenos L, Triantafyllis A, Tsinivizov P, Giannakopoulos A et al. Cardiac arrhythmias in arterial hypertension. J Clin Hypertens (Greenwich). 2020; 22(8): 1371-1378. DOI: 10.1111/jch.13989.
12. Xu TY, Yang Y, Li JJ, Li Y, Wang JG. Left ventricular deformation in relation to the geometric pattern in hypertensive patients. Medicine (Baltimore). 2019; 98 (4):e14257. DOI: 10.1097/MD.0000000000014257.

Publication:

«World of Medicine and Biology» Vol. 21 No. 93 (2025) , с. 94-99
УДК 616.12-008.331.1+616.12-005.4+616.12-009.72

DOI:

https://doi.org/10.26724/2079-8334-2025-3-93-94-99